Fisher Asset Management
CGEM icon

Fisher Asset Management’s Cullinan Oncology CGEM Stock Holding History

Fisher Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Buy
+35,998
New +$535K ﹤0.01% 759

Other funds holding CGEM

TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Fisher Asset Management's CGEM Position: Q2 2026 in Review

Fisher Asset Management opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 35,998 shares worth $656K. The stake represents ﹤0.01% of the portfolio and ranks #759 among its holdings.

34 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Fisher Asset Management held 35,998 shares of Cullinan Oncology worth $656K as of Q2 2026.
  • Cullinan Oncology was a new Fisher Asset Management position in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #759 holding.
  • 34 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.